XML 24 R11.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments
3 Months Ended
Dec. 31, 2021
Financial Instruments, Owned, at Fair Value [Abstract]  
Financial Instruments Financial Instruments
 
Long-Term Debt.  The fair market value of the Company’s debt, as presented in the table below, was determined using a discounted cash flow model, which incorporates the Company’s credit ratings and current market conditions in determining the
yield, and subsequently, the fair market value of the debt.  Based on these criteria, the fair market value of long-term debt, including current portion, was as follows (in thousands): 
 December 31, 2021September 30, 2021
 Carrying
Amount
Fair ValueCarrying
Amount
Fair Value
Long-Term Debt$2,629,602 $2,847,638 $2,628,687 $2,898,552 
 
    The fair value amounts are not intended to reflect principal amounts that the Company will ultimately be required to pay. Carrying amounts for other financial instruments recorded on the Company’s Consolidated Balance Sheets approximate fair value. The fair value of long-term debt was calculated using observable inputs (U.S. Treasuries for the risk free component and company specific credit spread information – generally obtained from recent trade activity in the debt).  As such, the Company considers the debt to be Level 2.
 
    Any temporary cash investments, notes payable to banks and commercial paper are stated at cost. Temporary cash investments are considered Level 1, while notes payable to banks and commercial paper are considered to be Level 2.  Given the short-term nature of the notes payable to banks and commercial paper, the Company believes cost is a reasonable approximation of fair value.

Other Investments. The components of the Company's Other Investments are as follows (in thousands):
At December 31, 2021At September 30, 2021
Life Insurance Contracts$45,599 $44,560 
Equity Mutual Fund25,442 34,433 
Fixed Income Mutual Fund35,442 70,639 
$106,483 $149,632 
 
    Investments in life insurance contracts are stated at their cash surrender values or net present value. Investments in an equity mutual fund and a fixed income mutual fund are stated at fair value based on quoted market prices with changes in fair value recognized in net income. The insurance contracts and equity mutual fund are primarily informal funding mechanisms for various benefit obligations the Company has to certain employees. The fixed income mutual fund is primarily an informal funding mechanism for certain regulatory obligations that the Company has to Utility segment customers in its Pennsylvania jurisdiction, as discussed in Note 11 — Regulatory Matters, and for various benefit obligations the Company has to certain employees.
 
Derivative Financial Instruments.  The Company uses derivative financial instruments to manage commodity price risk in the Exploration and Production segment. The Company enters into over-the-counter no cost collars and over-the-counter swap agreements for natural gas and crude oil to manage the price risk associated with forecasted sales of gas and oil. In addition, the Company also enters into foreign exchange forward contracts to manage the risk of currency fluctuations associated with transportation costs denominated in Canadian currency in the Exploration and Production segment. These instruments are accounted for as cash flow hedges. The duration of the Company’s cash flow hedges does not typically exceed 5 years while the foreign currency forward contracts do not exceed 9 years.

    The Company has presented its net derivative assets and liabilities as “Fair Value of Derivative Financial Instruments” on its Consolidated Balance Sheets at December 31, 2021 and September 30, 2021.  Substantially all of the derivative financial instruments reported on those line items relate to commodity contracts and a small portion relates to foreign currency forward contracts.
 
Cash Flow Hedges
 
    For derivative financial instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative is reported as a component of other comprehensive income (loss) and reclassified into earnings in the period or periods during which the hedged transaction affects earnings.
    As of December 31, 2021, the Company had the following commodity derivative contracts (swaps and no cost collars) outstanding:
CommodityUnits
Natural Gas371.2  Bcf
Crude Oil1,692,000  Bbls
    
    As of December 31, 2021, the Company was hedging a total of $56.7 million of forecasted transportation costs denominated in Canadian dollars with foreign currency forward contracts.

    As of December 31, 2021, the Company had $290.7 million ($213.4 million after-tax) of net hedging losses included in the accumulated other comprehensive loss balance. It is expected that $197.7 million ($145.1 million after-tax) of such unrealized losses will be reclassified into the Consolidated Statement of Income within the next 12 months as the underlying hedged transactions are recorded in earnings.
The Effect of Derivative Financial Instruments on the Statement of Financial Performance for the
Three Months Ended December 31, 2021 and 2020 (Thousands of Dollars)
Derivatives in Cash Flow Hedging RelationshipsAmount of Derivative Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on
the Consolidated Statement of
Comprehensive Income (Loss)
for the
 Three Months Ended
 December 31,
Location of Derivative Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) on the Consolidated Balance Sheet into the Consolidated Statement of IncomeAmount of Derivative Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) on the Consolidated Balance Sheet into the Consolidated Statement of Income for the
 Three Months Ended
 December 31,
 20212020 20212020
Commodity Contracts$163,126 $45,595 Operating Revenue$(162,629)$(310)
Foreign Currency Contracts2,426 Operating Revenue41 (1)
Total$163,132 $48,021  $(162,588)$(311)
Credit Risk
 
    The Company has over-the-counter swap positions, no cost collars and applicable foreign currency forward contracts with seventeen counterparties. The majority of the Company’s counterparties are financial institutions and energy traders. As of December 31, 2021, fifteen of the seventeen counterparties to the Company’s outstanding derivative financial instrument contracts (specifically the over-the-counter swaps, over-the-counter no cost collars and applicable foreign currency forward contracts) had a common credit-risk related contingency feature. In the event the Company’s credit rating increases or falls below a certain threshold (applicable debt ratings), the available credit extended to the Company would either increase or decrease. A decline in the Company’s credit rating, in and of itself, would not cause the Company to be required to post or increase the level of its hedging collateral deposits (in the form of cash deposits, letters of credit or treasury debt instruments). If the Company’s outstanding derivative financial instrument contracts with a credit-risk contingency feature were in a liability position (or if the liability were larger) and/or the Company’s credit rating declined, then hedging collateral deposits or an increase to such deposits could be required.  At December 31, 2021, the fair market value of the derivative financial instrument liabilities with a credit-risk related contingency feature was $235.2 million according to the Company’s internal model (discussed in Note 4 – Fair Value Measurements), and no hedging collateral deposits were required to be posted by the Company at December 31, 2021. Depending on the movement of commodity prices in the future, it is possible that these liability positions could swing into asset positions, at which point the Company would be exposed to credit risk on its derivative financial instruments. In that case, the Company's counterparties could be required to post hedging collateral deposits.
    
    The Company’s requirement to post hedging collateral deposits and the Company's right to receive hedging collateral deposits is based on the fair value determined by the Company’s counterparties, which may differ from the Company’s assessment of fair value.